help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shirakami, G.
Right arrow Articles by Imura, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shirakami, G.
Right arrow Articles by Imura, H.

Endocrinology, Vol 132, 1905-1912, Copyright © 1993 by Endocrine Society


ARTICLES

Low doses of endothelin-1 inhibit atrial natriuretic peptide secretion

G Shirakami, K Nakao, Y Saito, T Magaribuchi, M Mukoyama, H Arai, K Hosoda, S Suga, K Mori and H Imura
Department of Medicine, Kyoto University School of Medicine, Japan.

To clarify the interaction between endothelin-1 (ET-1) and atrial natriuretic peptide (ANP), the effects of ET-1 on ANP secretion were investigated in isolated perfused rat hearts and in conscious unrestrained rats. Perfusion with 10(-9) M ET-1 stimulated ANP secretion from the isolated perfused rat heart. However, 10(-10) M ET-1 significantly decreased ANP secretion for the initial 15 min of the perfusion period. The perfusion with 10(-11) M ET-1, which is near the plasma level of ET-1 (2 x 10(-12) M), inhibited ANP secretion throughout the perfusion period. The perfusion of 10(-12) M ET-1 slightly decreased ANP secretion. After the ET-1 perfusion period, ANP secretion increased in proportion to ET-1 dose. The inhibitory action of ET-1 on ANP secretion was almost abolished by simultaneous perfusion of indomethacin, a cyclooxygenase inhibitor, but not by methylene blue, an inhibitor of soluble guanylate cyclase. In conscious unrestrained rats the iv infusion of 1 pmol/kg.min ET-1, which doubled the plasma ET- 1 level, slightly but significantly decreased the plasma ANP level 5 and 10 min after the initiation of the infusion. The infusion of 10 and 30 pmol/kg.min ET-1 increased the plasma ANP level. These results demonstrate that low doses of ET-1 exert an inhibitory and short-acting action on ANP secretion from the heart, although high doses of ET-1 exert stimulating and long-lasting action, and suggest that prostanoids are involved in this inhibitory action.


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
I. Hamanaka, Y. Saito, T. Nishikimi, T. Magaribuchi, S. Kamitani, K. Kuwahara, M. Ishikawa, Y. Miyamoto, M. Harada, E. Ogawa, et al.
Effects of cardiotrophin-1 on hemodynamics and endocrine function of the heart
Am J Physiol Heart Circ Physiol, July 1, 2000; 279(1): H388 - H396.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
T. J. Acosta, B. Berisha, T. Ozawa, K. Sato, D. Schams, and A. Miyamoto
Evidence for a Local Endothelin-Angiotensin-Atrial Natriuretic Peptide Systemin Bovine Mature Follicles In Vitro: Effects on Steroid Hormones and Prostaglandin Secretion
Biol Reprod, December 1, 1999; 61(6): 1419 - 1425.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
H. Leskinen, O. Vuolteenaho, and H. Ruskoaho
Combined Inhibition of Endothelin and Angiotensin II Receptors Blocks Volume Load–Induced Cardiac Hormone Release
Circ. Res., January 1, 1997; 80(1): 114 - 123.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1993 by The Endocrine Society